BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/10/2014 5:06:00 PM | Browse: 1270 | Download: 936
 |
Received |
|
2013-04-13 14:53 |
 |
Peer-Review Started |
|
2013-04-14 13:46 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2013-05-09 09:17 |
 |
Revised |
|
2013-07-05 03:52 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2013-09-18 10:59 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2013-09-18 11:40 |
 |
Articles in Press |
|
|
 |
Edit the Manuscript by Language Editor |
|
2013-09-26 14:08 |
 |
Typeset the Manuscript |
|
2013-10-23 18:54 |
 |
Publish the Manuscript Online |
|
2013-10-25 08:47 |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Autobiography |
| Article Title |
Risk factors for liver fibrosis among human immunodeficiency virus monoinfected patients using the FIB4 index in Morocco
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Mohamed Tahiri, Mustapha Sodqi, Fatima Ez Zahra Lahdami, Latifa Marih, Hassan Lamdini, Wafaa Hliwa, Ahd Oulad Lahcen, Wafaa Badre, Fouad Haddad, Abdelfetah Chakib, Ahmed Bellabah, Rhimou Alaoui and Kamal Marhoum El Filali |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mohamed Tahiri, PhD, Department of Hepato-Gastro-Enterology, Ibn Rochd Hospital University Center, 187 Lotissement Mandarona Sidi Maarouf, Casablanca 20270, Morocco. docteurtahirimohamed@yahoo.fr
|
| Key Words |
Human immunodeficiency virus; FIB4; Liver; Monoinfected; Risk factors |
| Core Tip |
We evaluated, for the first time in Morocco, the prevalence and risk factors of significant hepatic fibrosis in Moroccan human immunodeficiency virus (HIV) monoinfected patients using the FIB4 score which represents a noninvasive, composite index that is a validated measure of hepatic fibrosis. FIB4 score > 1.45 was found in 15.5% of Moroccan HIV monoinfected patients. Age, HIV viremia > 75 copies/mL and CD4 count < 200 cells/mm3 are associated with liver fibrosis. Gender, duration of HIV infection, glycemia, use of antiretroviral therapy and antiretroviral therapy duration were not associated with significant fibrosis.
|
| Publish Date |
2013-10-25 08:47 |
| Citation |
Tahiri M, Sodqi M, Lahdami FEZ, Marih L, Lamdini H, Hliwa W, Lahcen AO, Badre W, Haddad F, Chakib A, Bellabah A, Alaoui R, El Filali KM. Risk factors for liver fibrosis among human immunodeficiency virus monoinfected patients using the FIB4 index in Morocco. World J Hepatol 2013; 5(10): 584-588
|
| URL |
http://www.wjgnet.com/1948-5182/full/v5/i10/584.htm |
| DOI |
http://dx.doi.org/10.4254/wjh.v5.i10.584 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.